Achieve Life Announces Participation at Investor Conferences
14 Nov 2024 //
GLOBENEWSWIRE
Achieve Life Reports Financial Results for Q3 2024 & Update
07 Nov 2024 //
GLOBENEWSWIRE
Achieve Life Sciences To Announce Q3 Results On Nov 7
24 Oct 2024 //
GLOBENEWSWIRE
Achieve Life Sciences President Speaks at Smoking Cessation Meeting
23 Oct 2024 //
GLOBENEWSWIRE
Achieve Life Promotes Jaime Xinos To Chief Commercial Officer
16 Oct 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Completes ORCA-OL Trial Enrollment
10 Oct 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Appoints Dr. Mark as Head of Medical Affairs
01 Oct 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Executive Leadership and Board Changes
26 Aug 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Changes In Leadership And Board Of Directors
26 Aug 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Reports Q2 2024 Results And Corporate Update
13 Aug 2024 //
GLOBENEWSWIRE
Achieve`s Cytisinicline Gets FDA Breakthrough Therapy Designation
31 Jul 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank
29 Jul 2024 //
GLOBENEWSWIRE
Achieve Life Sciences To Report Q2 Results On August 13
25 Jul 2024 //
GLOBENEWSWIRE
Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024
09 Jul 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Added To Russell 3000 And Microcap Indexes
01 Jul 2024 //
GLOBENEWSWIRE
Achieve Life Starts Long-Term Cytisinicline Study In Smokers/Vapers
29 May 2024 //
GLOBENEWSWIRE
Achieve Life Sciences ORCA-V1 Data At SGIM Meeting
17 May 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Q1 2024 Financials And Corporate Update
09 May 2024 //
GLOBENEWSWIRE
Achieve Publishes Cytisinicline Vaping Cessation Trial In JAMA
06 May 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Q1 2024 Results & Call On May 9
25 Apr 2024 //
GLOBENEWSWIRE
Achieve Life Sciences At Life Science Innovation Northwest 2024
11 Apr 2024 //
GLOBENEWSWIRE
Achieve Reports Financial Results for Fourth Quarter and Year-End 2023
28 Mar 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Cytisinicline ORCA Program to be Presented at 2024(SRNT)
20 Mar 2024 //
GLOBENEWSWIRE
Achieve Life to Announce Fourth Quarter and Year-End 2023 Financial Results
14 Mar 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
06 Mar 2024 //
GLOBENEWSWIRE
Achieve Life Announces Pricing of up to $124.2M Registered Direct Offering
29 Feb 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Reaches Agreement with the FDA
29 Feb 2024 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
11 Dec 2023 //
GLOBENEWSWIRE
Achieve Life Sciences Reports Financial Results for Third Quarter
09 Nov 2023 //
GLOBENEWSWIRE
Achieve Life Sciences to Announce Third Quarter 2023 Financial Results
26 Oct 2023 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
03 Oct 2023 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Presentation of ORCA-V1 Results
11 Sep 2023 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
07 Sep 2023 //
GLOBENEWSWIRE
Achieve Life Sciences Reports Financial Results for Second Quarter 2023
14 Aug 2023 //
GLOBENEWSWIRE
Achieve Life Sciences to Announce Second Quarter 2023 Financial Results
01 Aug 2023 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Presentation at 2023 Annual Meeting
18 Jul 2023 //
GLOBENEWSWIRE
Achieve Life Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in JAMA
11 Jul 2023 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
06 Jun 2023 //
GLOBENEWSWIRE
Achieve Life Announces Pricing of $16.5 Million Registered Direct Offering
25 May 2023 //
GLOBENEWSWIRE
PhIII win for smoking cessation puts Achieve Life on path to FDA
23 May 2023 //
ENDPTS
Achieve Life Sciences Reports Significant Smoking Cessation Benefit
23 May 2023 //
GLOBENEWSWIRE
Achieve Life Announces Refinancing of Outstanding Loan with Silicon Valley Bank
17 May 2023 //
GLOBENEWSWIRE
Achieve Life Sciences Reports FYR for 1Q 2023 and Provides Corporate Update
09 May 2023 //
GLOBENEWSWIRE
Achieve Life Sciences to Announce 1Q 2023 FYR and Host Conference Call
26 Apr 2023 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Positive Phase 2 ORCA-V1 Trial Results Showing
20 Apr 2023 //
GLOBENEWSWIRE
Achieve Life to Present at Life Science Innovation Northwest 2023 Conference
14 Apr 2023 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Refresh to Board of Directors
30 Mar 2023 //
GLOBENEWSWIRE
Final milestone reached in Cytisinicline Phase III trial
30 Mar 2023 //
CLINICAL TRIALS ARENA
Achieve Life Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial
29 Mar 2023 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Granting of New Hire Inducement Award
17 Mar 2023 //
GLOBENEWSWIRE
Achieve Life Sciences Reports Financial Results for Q4 & Year-End 2022
16 Mar 2023 //
GLOBENEWSWIRE
Achieve Life Announces Subject Last Visit Completed in Phase 2 ORCA-V1 Trial
08 Mar 2023 //
GLOBENEWSWIRE
Achieve Life presents positive data from ph3 ORCA-2 trial of cytisinicline
06 Mar 2023 //
PHARMABIZ
Achieve Life Announces Presentation of Phase 3 ORCA-2 Trial of Cytisinicline
03 Mar 2023 //
GLOBENEWSWIRE
Achieve Life to Announce Fourth Quarter and Year-End 2022 Financial Results
02 Mar 2023 //
GLOBENEWSWIRE
Achieve Life Announces Last Subject Dosed in PII ORCA-V1 Trial of Cytisinicline
07 Feb 2023 //
GLOBENEWSWIRE
Achieve Life to Participate at 2023 SVB Securities Global Biopharma Conference
02 Feb 2023 //
GLOBENEWSWIRE
Achieve Life Sciences Announces Granting of New Hire Inducement Award
27 Jan 2023 //
GLOBENEWSWIRE
Achieve Life Announces Last Subject Dosed in PIII ORCA-3 Trial of Cytisinicline
09 Jan 2023 //
PRESS RELEASE
Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline
21 Dec 2022 //
GLOBENEWSWIRE